000283087 001__ 283087
000283087 005__ 20260107144733.0
000283087 0247_ $$2doi$$a10.1002/alz70861_108535
000283087 0247_ $$2ISSN$$a1552-5260
000283087 0247_ $$2ISSN$$a1552-5279
000283087 037__ $$aDZNE-2025-01494
000283087 082__ $$a610
000283087 1001_ $$0P:(DE-2719)2000026$$aTeipel, Stefan J.$$b0$$eFirst author$$udzne
000283087 1112_ $$aAlzheimer’s Association International Conference$$cToronto$$d2025-07-27 - 2025-07-31$$gAAIC 25$$wCanada
000283087 245__ $$aThalamus but not basal forebrain and hippocampus atrophy in prodromal carriers of the Columbian mutation for autosomal dominant Alzheimer’s disease – a Bayesian confirmatory analysis
000283087 260__ $$c2025
000283087 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract$$babstract$$mabstract$$s1767100507_6287
000283087 3367_ $$033$$2EndNote$$aConference Paper
000283087 3367_ $$2BibTeX$$aINPROCEEDINGS
000283087 3367_ $$2DRIVER$$aconferenceObject
000283087 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
000283087 3367_ $$2DataCite$$aOutput Types/Conference Abstract
000283087 3367_ $$2ORCID$$aOTHER
000283087 520__ $$aBackground:In sporadic Alzheimer's Disease (AD), the cholinergic basal forebrain degenerates early, but seems to be preserved in the Colombian PSEN1-E280A genetic mutation for familial AD. In two cross-sectional studies analyzing basal forebrain volume and connectivity from the API Colombia cohort, we found no reduction in basal forebrain volume or connectivity in carriers, but observed reduced thalamic volume. Confirming these findings in other groups with the same genetic mutation, such as those in the Colombia-Boston (COLBOS) biomarker study, will help determine whether the new hypothesis about basal forebrain preservation in familial AD holds true.Method:We used multi-modal imaging (MRI, amyloid and tau-PET) data of 57 cognitively unimpaired individuals from the COLBOS study comprising PSEN1-E280A carriers (n = 27) and non-carriers (n =30). Staging of functional impairment was done using the Functional Assessment Staging Tool (FAST). Volumetry analyses were performed using basal forebrain, hippocampus and thalamus as regions of interest. We used Bayesian multiple regression with both flat and informed priors to test the hypothesis of preservation. As a secondary analysis, we investigated the associations of amyloid and tau pathology with brain volumes.Result:We found evidence for no effect of mutation carrier status on basal forebrain volume (BF₁₀: flat = 0.076; inf =0.54) and hippocampal volume (BF₁₀: flat =0.16; inf =1.05). In contrast, we observed moderate evidence for an effect of mutation carrier status on thalamus volume, with smaller volumes in mutation carriers (BF₁₀: flat =5.42; inf =8.74) (Figure 1). Lastly, we found strong evidence against an effect of amyloid status on basal forebrain and hippocampus, but moderate evidence for an effect on thalamic volume (Figure 2A). Similarly, tau pathology was not associated with basal forebrain, but showed associations with thalamus and hippocampus. (Figure 2B).Conclusion:Our findings show that in the PSEN1-E280A cohort, the cholinergic basal forebrain and hippocampus are not affected early in the disease, whereas the thalamus is, pointing to important considerations for treatment target selection in this group. These results should be further explored in other autosomal dominant AD mutations.
000283087 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000283087 588__ $$aDataset connected to CrossRef, Journals: pub.dzne.de
000283087 7001_ $$aBaena, Ana Y$$b1
000283087 7001_ $$aHe, Bing$$b2
000283087 7001_ $$aMartinez, Lusiana$$b3
000283087 7001_ $$aNiño, David Fernando Aguillón$$b4
000283087 7001_ $$aQuiroz, Yakeel T.$$b5
000283087 7001_ $$0P:(DE-2719)9001307$$aGrazia, Alice$$b6$$eLast author$$udzne
000283087 773__ $$0PERI:(DE-600)2201940-6$$a10.1002/alz70861_108535$$gVol. 21, no. S7, p. e108535$$nS7$$pe108535$$tAlzheimer's and dementia$$v21$$x1552-5260$$y2025
000283087 8564_ $$uhttps://pub.dzne.de/record/283087/files/DZNE-2025-1494.pdf$$yOpenAccess
000283087 8564_ $$uhttps://pub.dzne.de/record/283087/files/DZNE-2025-1494.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000283087 909CO $$ooai:pub.dzne.de:283087$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000283087 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000026$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000283087 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001307$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000283087 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000283087 9141_ $$y2025
000283087 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-06
000283087 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-06
000283087 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000283087 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000283087 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2025-01-06$$wger
000283087 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-06
000283087 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000283087 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-06
000283087 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000283087 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-06
000283087 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-06
000283087 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-06
000283087 9201_ $$0I:(DE-2719)1510100$$kAG Teipel$$lClinical Dementia Research (Rostock /Greifswald)$$x0
000283087 980__ $$aabstract
000283087 980__ $$aVDB
000283087 980__ $$aUNRESTRICTED
000283087 980__ $$ajournal
000283087 980__ $$aI:(DE-2719)1510100
000283087 9801_ $$aFullTexts